Article info

Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT

Authors

  1. Correspondence to Dr Stephen A Varvel; svarvel{at}hdlabinc.com
View Full Text

Citation

Varvel SA, Pottala JV, Thiselton DL, et al
Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT

Publication history

  • Received May 1, 2014
  • Revised August 22, 2014
  • Accepted September 1, 2014
  • First published September 24, 2014.
Online issue publication 
September 24, 2014
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.